Teladoc Health, Inc. (TDOC) stock
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3034% below fair value
$8.80+0.11 (+1.27%)
Close on Nov 13, 2026Market cap $1.60BP/E –Yield –
Teladoc Health operating margin
Operating margin is operating income as a percentage of revenue.
Teladoc Health's operating margin for the twelve months ending Sep 30, 2026 was -6.6%. For fiscal 2025 it was -10.4%, against -39.7% the year before. The highest annual figure on record is -9.6% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -10.4% | +29.3 |
| FY2024 | Dec 31, 2024 | -39.7% | −30.2 |
| FY2023 | Dec 31, 2023 | -9.6% | +557.7 |
| FY2022 | Dec 31, 2022 | -567.3% | −554.2 |
| FY2021 | Dec 31, 2021 | -13.1% | +33.2 |
| FY2020 | Dec 31, 2020 | -46.3% | −31.8 |
| FY2019 | Dec 31, 2019 | -14.5% | +2.4 |
| FY2018 | Dec 31, 2018 | -17.0% | +15.4 |
| FY2017 | Dec 31, 2017 | -32.3% | +18.6 |
| FY2016 | Dec 31, 2016 | -50.9% | +21.2 |
| FY2015 | Dec 31, 2015 | -72.1% | −37.3 |
| FY2014 | Dec 31, 2014 | -34.8% | −5.3 |
| FY2013 | Dec 31, 2013 | -29.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -4.6% | +3.7 |
| Q2 FY2026 | Jun 30, 2026 | -6.1% | +2.5 |
| Q1 FY2026 | Mar 31, 2026 | -10.1% | +9.1 |
| Q4 FY2025 | Dec 31, 2025 | -5.6% | +1.9 |
| Q3 FY2025 | Sep 30, 2025 | -8.3% | −1.4 |
| Q2 FY2025 | Jun 30, 2025 | -8.6% | +122.3 |
| Q1 FY2025 | Mar 31, 2025 | -19.2% | −5.7 |
| Q4 FY2024 | Dec 31, 2024 | -7.5% | −2.2 |
| Q3 FY2024 | Sep 30, 2024 | -6.9% | +2.9 |
| Q2 FY2024 | Jun 30, 2024 | -130.9% | −119.9 |
| Q1 FY2024 | Mar 31, 2024 | -13.5% | −1.2 |
| Q4 FY2023 | Dec 31, 2023 | -5.3% | +593.0 |
| Q3 FY2023 | Sep 30, 2023 | -9.8% | +1.9 |
| Q2 FY2023 | Jun 30, 2023 | -11.0% | +511.7 |
| Q1 FY2023 | Mar 31, 2023 | -12.3% | +1167.4 |
| Q4 FY2022 | Dec 31, 2022 | -598.3% | −590.8 |
| Q3 FY2022 | Sep 30, 2022 | -11.7% | −0.1 |
| Q2 FY2022 | Jun 30, 2022 | -522.7% | −507.0 |
| Q1 FY2022 | Mar 31, 2022 | -1179.7% | −1161.0 |
| Q4 FY2021 | Dec 31, 2021 | -7.5% | +112.1 |
| Q3 FY2021 | Sep 30, 2021 | -11.6% | −4.8 |
| Q2 FY2021 | Jun 30, 2021 | -15.7% | −12.7 |
| Q1 FY2021 | Mar 31, 2021 | -18.7% | −7.0 |
| Q4 FY2020 | Dec 31, 2020 | -119.6% | −109.7 |
| Q3 FY2020 | Sep 30, 2020 | -6.8% | +7.6 |
| Q2 FY2020 | Jun 30, 2020 | -3.0% | +13.9 |
| Q1 FY2020 | Mar 31, 2020 | -11.6% | +6.2 |
| Q4 FY2019 | Dec 31, 2019 | -10.0% | +4.6 |
| Q3 FY2019 | Sep 30, 2019 | -14.5% | −0.2 |
| Q2 FY2019 | Jun 30, 2019 | -16.9% | +2.3 |
| Q1 FY2019 | Mar 31, 2019 | -17.8% | +3.5 |
| Q4 FY2018 | Dec 31, 2018 | -14.5% | +17.3 |
| Q3 FY2018 | Sep 30, 2018 | -14.2% | +17.2 |
| Q2 FY2018 | Jun 30, 2018 | -19.2% | +13.3 |
| Q1 FY2018 | Mar 31, 2018 | -21.3% | +13.2 |
| Q4 FY2017 | Dec 31, 2017 | -31.8% | +3.5 |
| Q3 FY2017 | Sep 30, 2017 | -31.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -32.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -34.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -35.4% | – |
See a number that looks wrong?